Information Journal Paper
APA:
Copy. (2019). Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 59(-), 65-87. SID. https://sid.ir/paper/691302/en
Vancouver:
Copy. Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY[Internet]. 2019;59(-):65-87. Available from: https://sid.ir/paper/691302/en
IEEE:
Copy, “Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes,” ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, vol. 59, no. -, pp. 65–87, 2019, [Online]. Available: https://sid.ir/paper/691302/en